title: Quantum mechanics/molecular mechanics modeling of regioselectivity of drug metabolism in cytochrome P450 2C9.
abstract: Cytochrome P450 enzymes (P450s) are important in drug metabolism and have been linked to adverse drug reactions. P450s display broad substrate reactivity, and prediction of metabolites is complex. QM/MM studies of P450 reactivity have provided insight into important details of the reaction mechanisms and have the potential to make predictions of metabolite formation. Here we present a comprehensive study of the oxidation of three widely used pharmaceutical compounds (S-ibuprofen, diclofenac, and S-warfarin) by one of the major drug-metabolizing P450 isoforms, CYP2C9. The reaction barriers to substrate oxidation by the iron-oxo species (Compound I) have been calculated at the B3LYP-D/CHARMM27 level for different possible metabolism sites for each drug, on multiple pathways. In the cases of ibuprofen and warfarin, the process with the lowest activation energy is consistent with the experimentally preferred metabolite. For diclofenac, the pathway leading to the experimentally observed metabolite is not the one with the lowest activation energy. This apparent inconsistency with experiment might be explained by the two very different binding modes involved in oxidation at the two competing positions. The carboxylate of diclofenac interacts strongly with the CYP2C9 Arg108 side chain in the transition state for formation of the observed metabolite-but not in that for the competing pathway. We compare reaction barriers calculated both in the presence and in the absence of the protein and observe a marked improvement in selectivity prediction ability upon inclusion of the protein for all of the substrates studied. The barriers calculated with the protein are generally higher than those calculated in the gas phase. This suggests that active-site residues surrounding the substrate play an important role in controlling selectivity in CYP2C9. The results show that inclusion of sampling (particularly) and dispersion effects is important in making accurate predictions of drug metabolism selectivity of P450s using QM/MM methods.
authors: Centre for Computational Chemistry, School of Chemistry, University of Bristol, Cantock's Close, Bristol, BS8 1TS, UK.
authors: Richard
authors: R
authors: Lonsdale
authors: Kerensa T
authors: KT
authors: Houghton
authors: Jolanta
authors: J
authors: Żurek
authors: Christine M
authors: CM
authors: Bathelt
authors: Nicolas
authors: N
authors: Foloppe
authors: Marcel J
authors: MJ
authors: de Groot
authors: Jeremy N
authors: JN
authors: Harvey
authors: Adrian J
authors: AJ
authors: Mulholland
mesh_terms: D001189:Aryl Hydrocarbon Hydroxylases / Q000737:chemistry / Q000378:metabolism*; D018360:Crystallography, X-Ray; D065729:Cytochrome P-450 CYP2C9; D006801:Humans; D006900:Hydroxylation; D008958:Models, Molecular; D056004:Molecular Dynamics Simulation; D011789:Quantum Theory
chemical_list: C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases
references: J Phys Chem B. 2010 Jan 21;114(2):1156-62
references: 20014756
references: J Am Chem Soc. 2003 Dec 10;125(49):15004-5
references: 14653732
references: Arch Biochem Biophys. 1998 Sep 15;357(2):240-8
references: 9735164
references: Drug Metab Dispos. 1996 Sep;24(9):1038-45
references: 8886617
references: J Biol Chem. 2004 Aug 20;279(34):35630-7
references: 15181000
references: Clin Pharmacol Ther. 2004 Aug;76(2):119-27
references: 15289789
references: J Chem Phys. 2011 Feb 7;134(5):054114
references: 21303099
references: Drug Metab Dispos. 2008 Oct;36(10):1992-7
references: 18606741
references: Angew Chem Int Ed Engl. 2006 Oct 20;45(41):6856-9
references: 16991165
references: J Chem Theory Comput. 2012 Nov 13;8(11):4637-45
references: 26605619
references: Pharmacogenetics. 1996 Aug;6(4):341-9
references: 8873220
references: J Am Chem Soc. 2004 Jul 14;126(27):8362-3
references: 15237977
references: J Pharmacol Exp Ther. 1991 Dec;259(3):1133-9
references: 1762067
references: J Phys Chem A. 2008 Dec 18;112(50):13149-56
references: 18754597
references: Biochem Pharmacol. 1997 Jul 1;54(1):33-41
references: 9296349
references: Org Biomol Chem. 2006 Nov 7;4(21):3931-7
references: 17047872
references: Proteins. 2006 Jul 1;64(1):147-55
references: 16639745
references: J Am Chem Soc. 2004 Apr 28;126(16):5072-3
references: 15099082
references: J Am Chem Soc. 2011 May 18;133(19):7416-27
references: 21513309
references: Pharmacol Ther. 1997;73(1):67-74
references: 9014207
references: Phys Rev B Condens Matter. 1988 Jan 15;37(2):785-789
references: 9944570
references: J Comput Chem. 2006 Nov 30;27(15):1787-99
references: 16955487
references: Eur J Clin Pharmacol. 2001 Dec;57(10):729-35
references: 11829203
references: Biochemistry. 1999 Oct 26;38(43):14264-70
references: 10572000
references: Nature. 2003 Jul 24;424(6947):464-8
references: 12861225
references: Faraday Discuss. 2004;127:165-77
references: 15471345
references: Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11693-7
references: 8265610
references: Science. 2000 Mar 3;287(5458):1615-22
references: 10698731
references: J Chem Inf Model. 2012 Mar 26;52(3):617-48
references: 22339582
references: J Am Chem Soc. 2004 Mar 31;126(12):4017-34
references: 15038756
references: J Phys Chem B. 1998 Apr 30;102(18):3586-616
references: 24889800
references: Drug Metab Dispos. 1996 Feb;24(2):260-6
references: 8742240
references: Chem Soc Rev. 2012 Apr 21;41(8):3025-38
references: 22278388
references: Biochemistry. 2012 Feb 28;51(8):1774-86
references: 22280021
references: Br J Clin Pharmacol. 1985 May;19(5):669-74
references: 4005104
references: Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13926-31
references: 12242329
references: J Am Chem Soc. 2003 Oct 29;125(43):13024-5
references: 14570465
references: J Am Chem Soc. 2005 Sep 21;127(37):12900-8
references: 16159284
references: Biochemistry. 1989 Nov 14;28(23):9019-27
references: 2605239
references: Biochemistry. 1995 Aug 22;34(33):10365-75
references: 7654690
references: J Am Chem Soc. 2011 Oct 5;133(39):15464-74
references: 21863858
references: Chembiochem. 2012 Jan 23;13(2):215-23
references: 22190449
references: Biochemistry. 1996 Dec 17;35(50):16205-12
references: 8973193
references: J Med Chem. 2002 May 9;45(10):1983-93
references: 11985466
references: Science. 2010 Nov 12;330(6006):933-7
references: 21071661
references: J Med Chem. 1985 Aug;28(8):992-6
references: 4020838
references: Faraday Discuss. 2011;148:373-83; discussion 421-41
references: 21322494
references: J Am Chem Soc. 2004 Feb 18;126(6):1907-20
references: 14871124
references: J Am Chem Soc. 2003 Jun 18;125(24):7413-24
references: 12797816
references: J Am Chem Soc. 2011 May 25;133(20):7977-84
references: 21539368
references: Biochem Biophys Res Commun. 2000 Apr 21;270(3):983-7
references: 10772937
references: J Med Chem. 2005 Apr 21;48(8):2725-55
references: 15828810
references: Org Biomol Chem. 2004 Oct 21;2(20):2998-3005
references: 15480465
references: J Pharm Sci. 1976 Feb;65(2):269-73
references: 1255461
references: Mol Pharmacol. 2004 Apr;65(4):842-50
references: 15044613
references: Drug Metab Dispos. 1989 May-Jun;17(3):265-70
references: 2568906
references: Br J Clin Pharmacol. 2006 Nov;62(5):509-11
references: 17061959
references: Chem Res Toxicol. 1992 Jan-Feb;5(1):54-9
references: 1581537
references: J Med Chem. 1984 Aug;27(8):1092-5
references: 6747992
references: Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6050-5
references: 21444768
references: Proteins. 2005 Dec 1;61(4):704-21
references: 16231289